@@ -537,6 +537,49 @@ assert matches_aa_reduced(aa, mask(reduced, 3, AA_MASK))
537537
538538---
539539
540+ ## COVID-19 TCR Biomarker Notebooks
541+
542+ Three companion notebooks replicate and extend the findings of
543+ Vlasova * et al.* (2026) * Genome Med.*
544+ [ DOI:10.1186/s13073-025-01589-4] ( https://doi.org/10.1186/s13073-025-01589-4 )
545+ using 1 137 paired AIRR donors (761 COVID-19 / 376 healthy).
546+
547+ ### ` covid19_biomarkers.ipynb ` — Global Fisher scan and SVM classifier
548+
549+ - Public CDR3 panel: 4 093 TRB + 4 TRA candidates (≥ 5 % prevalence).
550+ - 39 TRB + 4 TRA CDR3s reach FDR < 0.05 (BH, one-sided Fisher);
551+ all TRB hits are healthy-enriched (public clonotype dilution by SARS-specific
552+ expansion), all TRA hits are COVID-enriched.
553+ - SVM classifier (RBF kernel, log-frequency features, 5-fold CV): AUC ≈ 0.70,
554+ replicating the paper's reported performance.
555+
556+ ### ` covid19_hla_biomarkers.ipynb ` — HLA × TCR stratification
557+
558+ - HLA allele–stratified sub-cohort Fisher tests (DRB1\* 16: n = 76,
559+ DQB1\* 05: n = 352).
560+ - Focused TRBV12-3/CASS replication test (1 297 pre-specified candidates,
561+ BH FDR within this set):
562+ - ** CASSRTGTGSSYNSPLHF** (TRBV12-3) — 26 COVID / 0 healthy DRB1\* 16 donors,
563+ log₂FE = 4.38, ** FDR = 0.035** .
564+ - 8 additional TRBV12-3 CDR3s with nc ≥ 5 / nh = 0.
565+ - Global HLA × CDR3 scan (83 alleles × 43 significant CDR3s):
566+ ** CAGQLYGGSQGNLIF** depleted in HLA-DPB1\* 02:01 donors (log₂FE = −1.51, q = 0.003).
567+
568+ ### ` covid19_pairing_biomarkers.ipynb ` — TRA × TRB co-occurrence and VDJdb overlap
569+
570+ - 156 TRA × TRB biomarker pairs tested (4 COVID-enriched TRA × 39 healthy-enriched TRB)
571+ across all-donor, COVID-only, and healthy-only strata.
572+ - One significant negative co-occurrence in all donors:
573+ ** CALSEETSGSRLTF × CASSLGGGDTQYF** (q = 0.027).
574+ - Healthy-only positive co-occurrence:
575+ ** CAGQNYGGSQGNLIF** with CASSLGETQYF (q = 0.001) and CASSPSTDTQYF (q = 0.013).
576+ - VDJdb 2025-12 cross-validation (Hamming ≤ 1, V-gene fixed):
577+ 3 / 4 TRA CDR3s confirmed as SARS-CoV-2-specific; 2 (CAGQNYGGSQGNLIF,
578+ CAGQLYGGSQGNLIF) target the Spike epitope NCTFEYVSQPFLMDL via TRAV35\* 01
579+ under HLA-DRB1\* 04:05 (class II); 15 / 39 TRB CDR3s match VDJdb records.
580+
581+ ---
582+
540583## Copilot Agent Workflow
541584
542585This repository ships a dedicated Copilot custom agent and companion prompt:
0 commit comments